Loading...
NPI 1700842358 · Southern Pines, NC · Ambulatory Surgical Clinic/Center
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
The Eye Surgery Center Of The Carolinas LP is a ambulatory surgical clinic/center provider located in Southern Pines, North Carolina. This profile covers 25 Medicare and 6 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | The Eye Surgery Center Of The Carolinas LP |
| Address | 2170 Midland Rd |
| City | Southern Pines |
| State | NC |
| ZIP | 28387 |
| Taxonomy | Ambulatory Surgical Clinic/Center |
| NPI Enumerated | April 23, 2006 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $3.1M |
| Medicaid | $813.9K |
THE EYE SURGERY CENTER OF THE CAROLINAS LP operates as an ambulatory surgical clinic/center with a clear ophthalmic surgery focus: the Medicare and Medicaid code mix is dominated by cataract extraction and intraocular lens insertion procedures (notably 66984 and related lens/device codes), with substantial use of intraoperative irrigation/anti-inflammatory medication codes such as J1097 and device/drainage implant codes such as 66991 and 66183. The presence of vitreoretinal (67042, 67036) and corneal transplant codes (65756, V2785) indicates the center also performs higher-complexity anterior and posterior segment procedures beyond routine cataract cases.
Medicare revenue is concentrated in a small number of high-value ophthalmic procedures: the precomputed top 3 Medicare codes (66984, 66991, J1097) account for 65.4% of the provider's total Medicare revenue, with 66984 alone reporting $1.4M (44.9% of Medicare revenue), 66991 $375.1K (12.0%), and J1097 $265.5K (8.5%). This concentration signals the business is largely driven by cataract and associated device/medication interventions on the Medicare side, making those code lines the primary revenue drivers and operational focus.
Medicaid billing is even more concentrated: the precomputed top 3 Medicaid codes account for 100.0% of the provider's total Medicaid revenue, with 66984 representing $800.6K and 98.3% of Medicaid revenue (4.1K claims at $193 avg paid/claim). In practical terms, Medicaid activity at this site is effectively single-service dominated—cataract extraction is the core Medicaid revenue stream, with only small supplementary contributions from C9447 ($12.9K, 1.6%) and a few low-revenue supply/implant codes.
On absolute scale, Medicare ($3.1M) is the larger payer for this provider compared with Medicaid ($813.9K), so overall operations are more Medicare-driven by revenue. Analysts should view strategic performance and payer risk primarily through the Medicare revenue base while noting Medicaid represents a meaningful but smaller portion of lifetime revenue.
This center shows notable competitive specialization for selected procedures: 66991 ranks #18 of 1445 providers nationally (99th percentile; extreme outlier) and 15823 ranks #12 of 1718 providers nationally (99th percentile; extreme outlier), indicating the facility delivers these less-common, higher-acuity or device-associated ophthalmic procedures at volumes well above typical peers. By contrast, 66984 is at rank #1133 of 15965 nationally (93rd percentile; described as typical, unremarkable volume), meaning routine cataract throughput is high but not uniquely exceptional nationally, while certain device/complex-procedure lines are distinct strengths.
Medicaid competitive standing underscores regional dominance in cataract surgery: 66984 ranks #2 of 74 in-state (99th percentile; extreme outlier) and C9447 ranks #1 of 3 in-state (100th percentile), which together signal this provider is a major state-level performer for cataract procedures and the associated intraoperative medication/devices used in those cases. For payers evaluating networks or competitive capacity in North Carolina, this center appears to be a principal outpatient cataract surgery site in its market.
Operational throughput indicators support a high-volume cataract program: the center reported 1.9K Medicare claims for 66984 (avg paid/claim $759) and 4.1K Medicaid claims for 66984 (avg paid/claim $193), plus 3.5K Medicare claims for J1097 (avg paid/claim $76). Those claim counts and the high absolute revenue for 66984 across both payers point to sustained surgical volume and routine use of intraoperative irrigation/anti-inflammatory agents, implying predictable supply and staffing patterns typical of dedicated ASC cataract programs.
Beyond cataract procedures, several ancillary revenue lines contribute to the provider's profile and suggest broader surgical capability: V2785 (corneal tissue processing) accounts for $147.6K of Medicare revenue and 15823 (upper eyelid skin trimming/blepharoplasty) contributes $151.5K, while corneal transplant code 65756 and glaucoma/shunt codes (66180, 66183) add meaningful mid-five-figure revenue. These entries indicate the center supports corneal, oculoplastic, and glaucoma device services in addition to routine cataract work, which diversifies case mix even as overall revenue remains concentrated in the top cataract-related codes.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
25 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 66984 | The provider inserts an artificial lens after removing an extracapsular cataract by aspiration or use of ultrasonic waves. This procedure is done without the use of an endoscopic laser probe to… | 1,850 | $760 | $1.4M |
| 66991 | The provider inserts an intraocular lens prosthesis during the same session as extracapsular cataract extraction. The provider also inserts one or more anterior segment aqueous drainage devices in… | 160 | $2,300 | $375.1K |
| J1097 | phenylephrine 10.16 mg/ml and ketorolac 2.88 mg/ml ophthalmic irrigation solution, 1 ml | 3,490 | $80 | $265.5K |
| 15823 | In this procedure, the provider surgically trims excessive skin that weighs down the upper eyelid, typically to improve the cosmetic appearance of the face and due to the interference of the tissue… | 330 | $460 | $151.5K |
| V2785 | Processing, preserving and transporting corneal tissue | 40 | $3,690 | $147.6K |
| 65820 | The provider incises the limbus to improve drainage of aqueous humor in the eye. This procedure is typically performed on children, usually to treat congenital glaucoma. | 160 | $770 | $125.1K |
| 66183 | The provider inserts a small device into the anterior chamber of the eye that helps to reduce the intraocular pressure of the eye in patients with glaucoma. | 50 | $2,060 | $92.5K |
| 67904 | The provider repairs a drooping eyelid by tightening the levator muscle that controls eyelid movement to improve cosmetic appearance or remove the obstruction to a patient’s vision. He accesses the… | 190 | $490 | $90.8K |
| 66982 | The provider inserts an intraocular lens prosthesis after extracapsular cataract extraction using complex techniques and devices. He may perform this by means of an iris expansion device, providing… | 90 | $770 | $65.2K |
| 67042 | In this procedure, the provider removes vitreous humor, the gelatinous material that gives shape to the eye, using a mechanical cutting tool. He removes the internal limiting membrane of the retina… | 40 | $1,360 | $58.4K |
Showing 1–10 of 25
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 25 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
25 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| J1097 | 3 | 10 | 1,240 | $80 | $151.9K |
| V2785 | 1 | 10 | 30 | $3,760 | $101.5K |
| 66984 | 124 | 580 | 230 | $70 | $73.7K |
| 66991 | 1 | 30 | 30 | $1,280 | $51.4K |
| 15823 | 2 | 50 | 50 | $520 | $40.3K |
| 66183 | 2 | 10 | 30 | $1,200 | $35.9K |
| 67904 | 2 | 40 | 30 | $570 | $31.7K |
| 65820 | 1 | 40 | 30 | $790 | $31.4K |
| 67042 | 4 | 30 | 20 | $990 | $23.8K |
| 66180 | 4 | 10 | 20 | $1,050 | $23.2K |
Showing 1–10 of 25
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
6 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 66984 | The provider inserts an artificial lens after removing an extracapsular cataract by aspiration or use of ultrasonic waves. This procedure is done without the use of an endoscopic laser probe to… | 4,150 | $190 | $800.6K |
| C9447 | Injection, phenylephrine and ketorolac, 4 ml vial | 160 | $80 | $12.9K |
| V2632 | Posterior chamber intraocular lens | 590 | $1 | $1.2K |
| G8907 | Patient documented not to have experienced any of the following events: a burn prior to discharge; a fall within the facility; wrong site/side/patient/procedure/implant event; or a hospital transfer… | 410 | $0 | $0 |
| G8918 | Patient without preoperative order for iv antibiotic surgical site infection (ssi) prophylaxis | 60 | $0 | $0 |
| J1097 | phenylephrine 10.16 mg/ml and ketorolac 2.88 mg/ml ophthalmic irrigation solution, 1 ml | 30 | $0 | $0 |
How this provider's Medicaid billing volume and revenue compare to other North Carolina providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. North Carolina median
6 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 66984 | The provider inserts an artificial lens after removing an extracapsular cataract by aspiration or use of ultrasonic waves. This procedure is done without the use of an endoscopic laser probe to… | 2 | 70 | 130 | $160 | $107.5K |
| C9447 | Injection, phenylephrine and ketorolac, 4 ml vial | 1 | 10 | 140 | $40 | $4.4K |
| V2632 | Posterior chamber intraocular lens | 5 | 30 | 70 | $10 | $3K |
| J1097 | phenylephrine 10.16 mg/ml and ketorolac 2.88 mg/ml ophthalmic irrigation solution, 1 ml | 2 | 10 | 20 | $40 | $2.6K |
| G8907 | Patient documented not to have experienced any of the following events: a burn prior to discharge; a fall within the facility; wrong site/side/patient/procedure/implant event; or a hospital transfer… | 14 | 60 | 170 | $0 | $0 |
| G8918 | Patient without preoperative order for iv antibiotic surgical site infection (ssi) prophylaxis | 24 | 40 | 70 | $0 | $0 |
Other providers in the same ZIP code as The Eye Surgery Center Of The Carolinas LP, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Sandhills Pediatrics | NC | Pediatrics Physician | $0 | $32.8M |
| Integrated Pain Solutions PLLC | NC | Interventional Pain Medicine Physician | $0 | $12.7M |
| Magnolia Gardens | NC | Assisted Living Facility | $0 | $8.3M |
| Arghavan Almony | NC | Ophthalmology Physician | $3.9M | $0 |
| Zeina Haddad | NC | Ophthalmology Physician | $2.7M | $0 |
| Kendall Wannamaker | NC | Ophthalmology Physician | $2.7M | $0 |
| Brooks Mays | NC | Endocrinology, Diabetes & Metabolism Physician | $569.7K | $0 |
| John French | NC | Ophthalmology Physician | $453.7K | $0 |
| Michol Stanzione | NC | Internal Medicine Physician | $433.8K | $0 |
| Tarra Millender | NC | Ophthalmology Physician | $391.9K | $0 |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.